English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

panic disorder/cannabis

The link is saved to the clipboard
ArticlesClinical trialsPatents
Page 1 from 27 results

Marijuana precipitation of panic disorder with agoraphobia.

Only registered users can translate articles
Log In/Sign up
We report the case of a 16-year-old adolescent with the onset of a panic disorder with agoraphobia after a first panic attack during marijuana intoxication. There was a good response to standard cognitive behavioural therapy for panic disorder.

Comorbid cannabis use and panic disorder: short term and long term follow-up study.

Only registered users can translate articles
Log In/Sign up
OBJECTIVE The aim of the study was to compare the treatment of panic disorder in patients with or without cannabis use according to response, relapse and side effects. METHODS 66 panic disorder (PD) patients were included in our study. All the subjects met the DSM-IV diagnosis of panic disorder

Association of cannabinoid receptor genes (CNR1 and CNR2) polymorphisms and panic disorder.

Only registered users can translate articles
Log In/Sign up
Background and objectives: Panic disorder (PD) is an anxiety disorder characterized by recurrent and unexpected panic attacks along with sudden onset of apprehension, fear or terror. The endocannabinoid system (ECS) has a role in stress recovery, regulating anxiety. The aim of this study was

Comparison of Cortisol Stress Response in Patients with Panic Disorder, Cannabis-Induced Panic Disorder, and Healthy Controls.

Only registered users can translate articles
Log In/Sign up
Little research effort has so far been dedicated to the analysis of the hypothalamic-pituitary-adrenal axis of aetiologically differing subgroups of patients with panic disorder (PD). The current study aimed at a deeper understanding of the cortisol stress response in cannabis-induced

Marijuana and panic disorder.

Only registered users can translate articles
Log In/Sign up

Marijuana (cannabis) use is anecdotally said to precipitate anxiety symptoms in patients with panic disorder. Is there any research evidence to support this? Also, can marijuana use precipitate or expose paranoia in patients with an underlying bipolar disorder?

Only registered users can translate articles
Log In/Sign up

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Only registered users can translate articles
Log In/Sign up
BACKGROUND In the 1990s, cannabis consumption in France increased considerably. So, in 10 years, the number of adolescents reporting regular cannabis use (10 or more times during the last 12 months) tripled. In 2004, an official program to address problems related to cannabis addiction was

Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray.

Only registered users can translate articles
Log In/Sign up
The present study investigated the effects of systemic or intra-dorsolateral periaqueductal gray (dlPAG) administration of CB1 agonists on behavioural changes induced in rats by predator (a live cat) exposure, a model of panic responses. Since nitric oxide (NO) and cannabinoid neurotransmission are

Correlates and 6-month outcomes for co-occurring cannabis use in rural and urban at-risk drinkers.

Only registered users can translate articles
Log In/Sign up
We know little about the functional correlates of recent cannabis use when such use is additional to an "alcohol disorder" in non-treatment populations. We report on data from a prospective study of a large probability community survey of 733 at-risk drinkers in six Southern U.S. states (Alabama,

Psychosis risk syndrome comorbid with panic attack disorder in a cannabis-abusing patient affected by Arnold-Chiari malformation type I.

Only registered users can translate articles
Log In/Sign up
OBJECTIVE An 18-year-old man with Arnold-Chiari malformation (ACM) type I developed sudden panic attacks. He also manifested sleep disorder, cannabis abuse, and psychosis-risk syndrome (PRS). Although with average-superior intelligence, he had executive dysfunction. This prompted us to explore the

[Comorbidity in 207 cannabis users in a specific outpatient setting].

Only registered users can translate articles
Log In/Sign up
BACKGROUND Health care seeking for a problematic use of cannabis is in progress in France. OBJECTIVE The aim is to assess the addictive and psychiatric comorbidity in cannabis users seen in the specific setting at the Lariboisière hospital. METHODS Two hundred and seven cannabis users were included

Cannabis expectancies in substance misusers: French validation of the Marijuana Effect Expectancy Questionnaire.

Only registered users can translate articles
Log In/Sign up
The aim of this study was to evaluate the psychometric properties of the French version of the Marijuana Effect Expectancy Questionnaire (48 items) and study the cannabis expectancies according to the patterns of substance use and psychiatric disorders (DSM-IV). A sample of 263 subjects (average age

Marijuana use and panic psychopathology among a representative sample of adults.

Only registered users can translate articles
Log In/Sign up
This study examined the relations between marijuana use and panic attacks and panic disorder using a large representative survey of adults (N = 5,672; 53% women; M(age) = 45.05 years, SD = 17.9) conducted in the United States (Kessler et al., 2004). After adjusting for sociodemographic variables

Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack.

Only registered users can translate articles
Log In/Sign up
Selective stimulation of carotid chemoreceptors by intravenous infusion of low doses of potassium cyanide (KCN) produces short-lasting escape responses that have been proposed as a model of panic attack. In turn, preclinical studies suggest that facilitation of the endocannabinoid system attenuate

Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation.

Only registered users can translate articles
Log In/Sign up
The endocannabinoid system has been implicated in the modulation of behaviors related to anxiety and panic disorders. Accordingly, facilitation of CB1 receptor signaling reduces the consequences of aversive stimuli in animal models. However, the role of the CB1 receptor in the
Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge